Heart Failure With Reduced Ejection Fraction (HFrEF) Clinical Trial
Official title:
International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients With Reduced Ejection Fraction
International, Multicentre, Parallel-group, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the effect of Dapagliflozin on Exercise Capacity in Heart Failure Patients with Reduced Ejection Fraction (HFrEF)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05328752 -
Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)
|
Phase 1 | |
Recruiting |
NCT05420012 -
The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation
|
Phase 4 | |
Active, not recruiting |
NCT05136820 -
Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study
|
N/A | |
Not yet recruiting |
NCT04304560 -
Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial
|
Phase 2 | |
Completed |
NCT04180696 -
Mid-Q Response Study
|
N/A | |
Recruiting |
NCT04331769 -
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
|
N/A | |
Recruiting |
NCT04860596 -
The Effectiveness of Collaborative Health Management Model on Heart Failure Patient
|
N/A |